Contineum Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -33.4% | -33.4% | 17.4% |
| FY2024 | -21.3% | -21.3% | -19.9% |
| FY2025 | -23.0% | -23.0% | -21.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -33.4% | -33.4% | 17.4% |
| FY2024 | -21.3% | -21.3% | -19.9% |
| FY2025 | -23.0% | -23.0% | -21.7% |